載入...
A93 NO INCREASE IN IMMUNOMODULATOR USE IN COMBINATION WITH ANTI-TNF THERAPY IN THE POST SONIC ERA
BACKGROUND: The SONIC trial in 2010 definitively proved the superiority of anti tumor necrosis factor (anti-TNF) therapy in combination with thiopurines over anti-TNF monotherapy in persons with moderate to severe CD. Despite high-quality evidence supporting combination therapy, there is a scarcity...
Na minha lista:
| 發表在: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508272/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.093 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|